Definitive Healthcare Corp Stock Analysis
| DH Stock | USD 0.95 0.01 1.52% |
200 Day MA 2.6308 | 50 Day MA 1.1587 | Beta 1.6 |
Macro event markers
DH is currently reading as below model estimate relative to an analyst target price of $2.41. The starting point for DH is whether the market price reflects the underlying business economics. Intrinsic value anchors what DH may be worth independent of current market pricing. Fundamental and technical signals for DH are examined to identify alignment or divergence. With profitability currently negative, the analytical focus for DH centers on cost structure and the path to margin recovery.
DH holds a debt-to-equity ratio of 0.19 relative to health care peers. After subtracting cash and equivalents, Net Debt To EBITDA stood at -0.0875 as of December 31, 2025. As of this month, Interest-Bearing Debt Per Share is 3.25 based on the most recent filings, while Net Debt is under 13.5 M. Rising leverage combined with declining revenue creates a compounding risk dynamic for DeFinitive Healthcare. Dividend capacity can be constrained when debt covenants prioritize creditor claims over shareholder distributions. Asset vs Debt
Equity vs Debt
Price Book 0.3789 | Enterprise Value Ebitda 46.6922 | Price Sales 0.441 | Shares Float 37.3 M | Wall Street Target Price 2.4125 |
Definitive Healthcare Corp's financial profile includes Net Income down $2.4 million year-over-year, a net loss of $199.3 million, and a net loss attributable to common shareholders of $7.3 million.
DeFinitive |
Stock Analysis Notes
About 88.0% of DH shares are held by institutions such as insurance companies. DH has price-to-book (P/B) ratio of 0.38. Equities trading at this Price to Book (P/B) range may carry value potential, though margin and return quality should confirm. DH has Price/Earnings To Growth (PEG) ratio of 1.03. DH reported a loss per share of 1.3. The firm had not issued any dividends in recent years. Definitive Healthcare Corp's financial profile includes $0.86 in Intangibles To Total Assets, $735.5 million in Total Assets, and a Return On Assets of -20.0%.Gross Profit | 160.36 Million |
Investor Insights and Alerts
| DeFinitive Healthcare generated a negative expected return over the last 90 days | |
| DeFinitive Healthcare has high historical volatility and very poor performance | |
| DeFinitive Healthcare has some characteristics of a very speculative penny stock | |
| DeFinitive Healthcare has a very high chance of going through financial distress in the upcoming years | |
| DH generated yearly revenue of 241.52 M. Annual Net Loss to common stockholders was -199.3 M with gross profit of 203.57 M. | |
| DeFinitive Healthcare has a poor financial position based on the latest SEC disclosures | |
| Latest headline from MacroaxisInsider: Disposition of 16342 shares by Shamsuddin Kate Marie of De Finitive Healthcare at 4.86 subject to Rule 16 b-3 |
Largest EPS Surprises
For DeFinitive Healthcare, consensus-versus-actual EPS differences are a core event driver. Forecasts are usually built from management commentary plus analyst model scenarios. For this stock, read EPS surprises with profitability quality and forward revisions.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-02-26 | 2024-12-31 | 0.0718 | 0.08 | 0.0082 | 11 | ||
2025-11-06 | 2025-09-30 | 0.06 | 0.07 | 0.01 | 16 | ||
2024-02-28 | 2023-12-31 | 0.08 | 0.07 | -0.01 | 12 |
Top Institutional Investors Holding DeFinitive Stock
At micro-cap scale, institutional coverage and secondary-market liquidity are typically well established. At Definitive Healthcare Corp's scale, fund flows and index rebalancing drive most of the daily volume. The business currently sits in the Health Care sector and the Health Care Equipment & Services industry. Volume spikes around index rebalance dates warrant attention given the high institutional share.
| Shares | Aqr Capital Management Llc | 2025-12-31 | 563.7 K | Renaissance Technologies Corp | 2025-12-31 | 527.6 K | Northern Trust Corp | 2025-09-30 | 490.9 K | Bank Of America Corp | 2025-09-30 | 410.9 K | Ubs Group Ag | 2025-09-30 | 376.9 K | Charles Schwab Investment Management Inc | 2025-12-31 | 358.9 K | Millennium Management Llc | 2025-12-31 | 332.1 K | Citadel Advisors Llc | 2025-12-31 | 290.3 K | Pinnacle Associates Inc | 2026-03-31 | 260 K | Advent International Lp | 2025-12-31 | 62.5 M | The Goldman Sachs Group Inc | 2025-12-31 | 5.9 M |
Market Capitalization
Current market cap data values Definitive Healthcare Corp at 106.51 M, which keeps the company in the small-cap bracket across health care technology companies. Additional sizing evidence includes about 105.46 M shares outstanding, a workforce of about 678 people, and enterprise value near 98.29 M.Profitability
A profitability review of Definitive Healthcare Corp connects sales quality and cost control with the ability to produce steady returns across market cycles. Annual revenue is about 241.52 Million. Comparing gross, operating, and net margins isolates where margin strength or pressure originates. DH has Net Profit Margin (PM) of -58.0 %, which may indicate that the company does not effectively execute on its pricing strategies. This is well below the sector average. Likewise, it shows Net Operating Margin (NOM) of -11.0 %, which signifies that for every $100 of sales, the company has a net operating loss of $11.0.| Last Reported | End Of Year Estimate | ||
| Return On Tangible Assets | -0.48 | -0.50 | |
| Return On Capital Employed | -0.04 | -0.04 | |
| Return On Assets | -18.89% | -20.00% | |
| Return On Equity | -49.42% | -52.00% |
Management Efficiency
DH has Return on Asset (ROA) of -1.41 % which means that for every $100 of assets, it generated a loss of $1.41. This is well below the sector average. Likewise, it shows a return on total equity (ROE) of -40.42 %, which implies that it generated no returns to current stockholders.| Last Reported | End Of Year Estimate | ||
| Book Value Per Share | 3.55 | 3.38 | |
| Tangible Book Value Per Share | -0.62 | -0.65 | |
| Enterprise Value Over EBITDA | -1.98 | -1.88 | |
| Price Book Value Ratio | 1.09 | 1.03 | |
| Enterprise Value Multiple | -1.98 | -1.88 | |
| Price Fair Value | 1.09 | 1.03 | |
| Enterprise Value | 320.3 M | 304.3 M |
Management quality at Definitive Healthcare Corp matters because strategic decisions eventually show up in margins, cash conversion, capital allocation, and the market's willingness to assign a premium multiple. This analysis evaluates whether leadership is improving the economics of the business in ways that can persist once the operating environment deteriorates.
Operating Margin | Long Term Debt Total | Short Long Term Debt Total | Expected Return -1.29 | Beta 1.6 |
Technical Drivers
As of the 30th of April, DeFinitive Healthcare reflects a market price of 0.95 per share. Current technical metrics show Mean Deviation of 3.82, variance of 24.88, and Standard Deviation of 4.99. Technical analytics evaluate momentum, liquidity, and volatility relationships. Low nominal pricing elevates liquidity risk considerations. Current statistics are evaluated within a broader sector context.Price Movement Analysis - Bollinger Bands
This analysis covers twenty-six data points across the selected time horizon. The Simple Moving Average indicator is calculated by adding the closing price of DeFinitive Healthcare for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out DeFinitive Healthcare short-term fluctuations and highlight longer-term trends or cycles.
Insider Trading Activities
Reviewing insider trades in Definitive Healthcare Corp shows whether management is acting in line with the public story on growth and strategy. U.S. insider activity is disclosed through Form 4 filings, enabling analysis of transaction timing, clustering, and scale.
Outstanding Bonds
Definitive Healthcare Corp may use bonds as part of its capital structure to fund operations, refinance liabilities, or support acquisitions and other long-duration investments. Maturity profile, refinancing windows, and coupon burden can all affect how resilient the capital structure looks in a weaker market.
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Predictive Daily Indicators
For active positions in Definitive Healthcare Corp, intraday data shows when a move is gaining strength and when it is fading. Used carefully, they can improve execution without tempting investors to overtrade every small swing.
| Accumulation Distribution | 10884.44 | |||
| Daily Balance Of Power | 0.2383 | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 0.93 | |||
| Day Typical Price | 0.94 | |||
| Price Action Indicator | 0.0314 | |||
| Period Momentum Indicator | 0.0143 |
Forecast Models
Forecast models for Definitive Healthcare Corp use past prices and returns to estimate how the stock may behave under similar conditions. Forecast models complement fundamental research by showing where price behavior supports or contradicts the thesis.Financial Strength and Earnings Quality Indicators
Definitive Healthcare Corp financial ratings play a critical role in determining how much DeFinitive Healthcare have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for DeFinitive Healthcare's borrowing costs.| Piotroski F Score | 4 | Poor | View |
| Beneish M Score | -2.43 | Unlikely Manipulator | View |
Debt to Cash Allocation
The debt-to-cash mix for DeFinitive Healthcare helps explain how management balances flexibility and funding cost through a business cycle.
Total debt stands at approximately $177.82 M with total debt to equity ratio (D/E) of 0.19. DH has a current ratio of 3.25, indicating that it is in good position to pay out its debt commitments in time. That said, strategic use of leverage may enable DeFinitive to fund expansion initiatives, though the impact on returns depends on execution and market conditions. Total Assets Over Time
Assets Financed by Debt
Debt finances 22.0% of DH's total assets — a relatively low share of the asset base, though leverage can still appear elevated relative to peers when measured against equity rather than total assets.DeFinitive Healthcare Debt Ratio | 22.0 |
Corporate Bonds Issued
Bond maturity for DeFinitive Healthcare is a core risk dimension. Longer duration can offer higher yield, but price sensitivity and credit uncertainty also increase.
DeFinitive Short Long Term Debt Total
Short Long Term Debt Total | 245.33 Million |
Stock Analysis Methodology
DeFinitive Healthcare analysis highlights where fundamental and technical signals point to strengths or weak spots. A beta of 1.502 indicates amplified sensitivity to market swings. DeFinitive Healthcare trades at P/B of 0.38, P/S of 0.44.
Definitive Healthcare Corp data is compiled from periodic company reporting and market reference feeds and standardized for comparability.
Editorial review and methodology oversight provided by: Raphi Shpitalnik, Junior Member of Macroaxis Editorial Board
Current DeFinitive Analyst Rating Consensus
| Target Price | Consensus | # of Analysts | |
| 2.41 | Buy | 14 | Odds |
The analyst consensus for Definitive Healthcare Corp is compiled from recommendations across research providers. The average consensus rating provides a summary measure of analyst sentiment for DeFinitive Healthcare. Research analysts covering DeFinitive use a range of valuation methodologies to derive price targets for DeFinitive Healthcare. DeFinitive's consensus rating summarizes the prevailing view, while individual targets reveal the valuation range. Analyst target prices for DeFinitive Healthcare are typically set with a 12-month horizon and revised each earnings cycle.
DeFinitive Stock Analysis Indicators
Diagnostics snapshot includes 23 indicators such as Begin Period Cash Flow, Total Stockholder Equity, Capital Lease Obligations.
| Begin Period Cash Flow | 105.4 M | |
| Total Stockholder Equity | 281.1 M | |
| Capital Lease Obligations | 7.8 M | |
| Property Plant And Equipment Net | 18.1 M | |
| Cash And Short Term Investments | 180.9 M | |
| Cash | 163.6 M | |
| 50 Day M A | 1.1587 | |
| Net Interest Income | -4.3 M | |
| Total Current Liabilities | 156.8 M | |
| Forward Price Earnings | 6.3131 | |
| Investments | 170.6 M | |
| Interest Expense | 11.3 M | |
| Stock Based Compensation | 29.1 M | |
| Long Term Debt | 156.1 M | |
| Common Stock Shares Outstanding | 106.7 M | |
| Total Cashflows From Investing Activities | 153.9 M | |
| Tax Provision | -10 M | |
| Accounts Payable | 3.6 M | |
| Net Debt | 14.2 M | |
| Other Operating Expenses | 262.1 M | |
| Non Current Assets Total | 477.9 M | |
| Liabilities And Stockholders Equity | 735.5 M | |
| Non Currrent Assets Other | 15.1 M |